The Cystic Fibrosis Foundation has awarded a milestone payment totaling $645,000 to Hollis-Eden Pharmaceuticals. The company earned the payment by meeting specific development milestones under an existing collaboration agreement with the Foundation to develop novel, anti-inflammatory therapies for people with CF.
|
1 min read
Share this article
Topics
About the CF Foundation
|
Drug Pipeline
Cystic Fibrosis Foundation Awards 2023 Impact Grants
News |
5 min read
Adult with CF Provides Testimony at Congressional Hearing on the Impact of Antimicrobial Resistance
News |
3 min read
Teens Advocate on Capitol Hill During the Foundation’s 15th Annual Teen Advocacy Day
News |
3 min read
Stay up to date with The Foundation
Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.